The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Hippocampal apolipoprotein D level depends on Braak stage and APOE genotype
Abstract
Apolipoprotein (APO, gene; apo, protein) D, a member of the lipocalin family, has been implicated in several, pathological conditions but neither its physiologic function(s) nor ligand(s) has been clearly identified so far. Presuming a role in nerve de- and regeneration, several groups investigated apoD alterations in Alzheimer's disease (AD). Reported data, however, were not unanimous. We determined apoD protein levels in the hippocampus in a large, carefully matched autopsy case sample. ApoD levels were compared with the severity of neuropathological changes as determined by the Braak classification and with APOE genotype, a major risk factor for developing AD. ApoD was found to be related to the severity of AD-related neurofibrillary (NF) changes and not to old age alone. No correlation was found to amyloid deposits. Brain samples with widespread NF changes showed significantly higher apoD than cases with low Braak stages. This increase, however, was restricted to the APOE epsilon3/3 group, whereas the APOE epsilon4 group did not show significant variations in hippocampal apoD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ApoD levels increase in Alzheimer's disease, but this increase appears limited to ε3/3 carriers compared to ε4/4 carriers.
“ApoD levels increase in AD though this increase appears to be limited to ε3/3 carriers compared to ε4/4 carriers [140, 141].”
From ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer’s disease and related disorders (2026) · cites this paper as [141]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The lipocalin protein family: structure and function
FLOWER, D. R. (1996) · Biochemical Journal · doi:10.1042/bj3180001 · Cited by 1,679
Flagged first, then by citations
Research works printed but not linked: 32
- Ackermann, 1991, BIAS, Comp Stat, 11, 223
- Balbin, 1990, Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease, Biochem J, 271, 803, 10.1042/bj2710803 · DOI
- Belloir, 2001, Altered apolipoprotein D expression in the brain of patients with Alzheimer disease, J Neurosci Res, 64, 61, 10.1002/jnr.1054 · DOI
- Boyles, 1990, Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve, J Biol Chem, 265, 17805, 10.1016/S0021-9258(18)38235-8 · DOI
- Drayna, 1986, Cloning and expression of human apolipoprotein D cDNA, J Biol Chem, 261, 16535, 10.1016/S0021-9258(18)66599-8 · DOI
- Franz, 1999, Increased expression of apolipoprotein D following experimental traumatic brain injury, J Neurochem, 73, 1615, 10.1046/j.1471-4159.1999.0731615.x · DOI
- Glöckner, 2002, Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease, Neuroscience, 114, 11103, 10.1016/S0306-4522(02)00178-1 · DOI
- Harr, 1996, Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease, J Neurochem, 66, 2429, 10.1046/j.1471-4159.1996.66062429.x · DOI
- Kalman, 2000, Apolipoprotein D in the aging brain and in Alzheimer's dementia, Neurol Res, 22, 330, 10.1080/01616412.2000.11740678 · DOI · Paper page
- Kesner, 1988, Proteases in cyst fluid from human gross cyst breast disease, Cancer Res, 48, 6379
- Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0 · DOI · Paper page
- Lea, 1988, Binding properties of progesterone-binding Cyst protein (PBCP), Steroids, 52, 337, 10.1016/0039-128X(88)90135-3 · DOI
- McConathy, 1973, Isolation and partial characterization of apolipoprotein D, a new protein moiety of the human plasma lipoprotein system, FEBS Lett, 37, 178, 10.1016/0014-5793(73)80453-3 · DOI
- Montpied, 1999, Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity, Epilepsy Res, 35, 135, 10.1016/S0920-1211(99)00003-0 · DOI
- Morais Cabral, 1995, Arachidonic acid binds to apolipoprotein D, implications for the protein's function, FEBS Lett, 366, 53, 10.1016/0014-5793(95)00484-Q · DOI
- Ohm, 1995, Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes, Neuroscience, 64, 209, 10.1016/0306-4522(95)90397-P · DOI
- Ohm, 1999, Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions, Acta Neuropathol Berl, 98, 273, 10.1007/s004010051080 · DOI
- Ong, 1997, Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus, Neuroscience, 79, 359, 10.1016/S0306-4522(96)00608-2 · DOI
- Pearlman, 1973, A specific progesterone-binding component of human breast cyst fluid, J Biol Chem, 248, 5736, 10.1016/S0021-9258(19)43566-7 · DOI
- Peitsch, 1990, Is apolipoprotein D a mammalian bilin-binding protein?, New Biol, 2, 197
- Provost, 1990, Molecular characterization and differential mRNA tissue distribution of rabbit apolipoprotein D, J Lipid Res, 31, 2057, 10.1016/S0022-2275(20)42270-9 · DOI
- Rassart, 2000, Apolipoprotein D, Biochim Biophys Acta, 1482, 185, 10.1016/S0167-4838(00)00162-X · DOI · Paper page
- Saunders, 1993, Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43, 1467, 10.1212/WNL.43.8.1467 · DOI · Paper page
- Smith, 1990, Cellular localization of apolipoprotein D and lecithin, cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization, J Lipid Res, 31, 995, 10.1016/S0022-2275(20)42739-7 · DOI
- Spreyer, 1990, Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve, EMBO J, 9, 2479, 10.1002/j.1460-2075.1990.tb07426.x · DOI
- Steyrer, 1988, Activation of lecithin-cholesterol acyltransferase by apolipoprotein D, comparison of proteoliposomes containing apolipoprotein D, A-I or C-I, Biochim Biophys Acta, 958, 484, 10.1016/0005-2760(88)90235-4 · DOI
- Strittmatter, 1993, Apolipoprotein E, Proc Natl Acad Sci USA, 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
- Sun, 1998, AP30, a differential protein marker for perilymph and cerebrospinal fluid in middle ear fluid, has been purified and identified as human apolipoprotein D, Biochim Biophys Acta, 1384, 405, 10.1016/S0167-4838(97)00198-2 · DOI
- Terrisse, 1998, Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients, J Neurochem, 71, 1643, 10.1046/j.1471-4159.1998.71041643.x · DOI
- Terrisse, 1999, Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion, Brain Res Mol Brain Res, 70, 26, 10.1016/S0169-328X(99)00123-0 · DOI
- Thomas, 2001, Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice, J Neurochem, 79, 1059, 10.1046/j.1471-4159.2001.00654.x · DOI
- Zeng, 1996, A human axillary odorant is carried by apolipoprotein D, Proc Natl Acad Sci USA, 93, 6626, 10.1073/pnas.93.13.6626 · DOI
Cited by
Sorted by citations
Cholesterol metabolism in neurons and astrocytes
Pfrieger, F. W., & Ungerer, N. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.002 · Cited by 500
Lipocalins - a family portrait
Grzyb, J., Latowski, D., & Strzałka, K. (2006) · Journal of Plant Physiology · doi:10.1016/j.jplph.2005.12.007 · Cited by 205
High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease
Pedrini, S., Chatterjee, P., Hone, E., & Martins, R. N. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15170 · Cited by 22
Strickland, M. R., & Holtzman, D. M. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00970-0
Metadata
- Authors
- Glöckner, F., & Ohm, T. G.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 122
- Issue
- 1
- Pages
- 103-110
- ISSN
- 0306-4522
- Cited by
- 22
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review